Intestinal or Multivisceral Transplant Research

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Intestine and Multivisceral Transplant Program

Boston Children’s Hospital is home to the world’s most extensive research enterprise at a pediatric hospital. At the Intestinal/Multivisceral Transplant Program, our treatment is informed by our research.

We also have a great number of partnerships with the top research, biotech and health care organizations in Boston, working together to improve kids’ health.

Innovative procedure may prevent intestinal transplantation

Boston Children's investigators are responsible for many clinical and research firsts. Heung Bae Kim, MD, surgical director of the Pediatric Transplant Center, and Tom Jaksic, MD, PhD, surgical director of CAIR, developed the serial transverse enteroplasty, or STEP, procedure for short bowel syndrome (SBS). This surgical procedure lengthens the bowel of children with SBS and may allow some to wean completely from parenteral nutrition and avoid the need for intestinal transplantation. Once considered an exciting new innovation, STEP is now the preferred intestinal lengthening procedure throughout the world. Watch a webcast video of STEP here.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close